Table 2.
Formulation | mAb Concentration(mg/mL) | Tg’ (°C) | Tc (°C) |
---|---|---|---|
FS | 10 | −29.5 | −31.0 |
50 | −25.4 | −20.4 | |
FCD | 10 | −10.9 | −10.1 |
50 | −8.3 | −6.3 | |
FCD/P/S | 10 | −19.2 | −18.5 |
50 | −16.5 | −14.6 | |
FCD/S | 10 | −18.6 | −16.0 |
50 | −15.2 | −10.9 |
Formulation | mAb Concentration(mg/mL) | Tg’ (°C) | Tc (°C) |
---|---|---|---|
FS | 10 | −29.5 | −31.0 |
50 | −25.4 | −20.4 | |
FCD | 10 | −10.9 | −10.1 |
50 | −8.3 | −6.3 | |
FCD/P/S | 10 | −19.2 | −18.5 |
50 | −16.5 | −14.6 | |
FCD/S | 10 | −18.6 | −16.0 |
50 | −15.2 | −10.9 |